듀켐바이오

176750KOSDAQ의약품 제조업

47.6 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment20.6 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but PER raises overvaluation concerns. Plunged 33.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dukem Bio is a company specializing in the development, manufacturing, and sales of radiopharmaceuticals for cancer and brain diseases, holding the largest number of PET-CT radiopharmaceutical products in South Korea. In 2025, it achieved revenue of 38.57 billion won and operating profit of 7.44 billion won, maintaining a market share leadership in key product lines such as FDG and Alzheimer's diagnostic agents. By acquiring RadioDnS Labs in 2024, the company is enhancing its R&D capabilities and aiming to become a global leader in radiopharmaceuticals.

Number of Employees

144people

Average Salary

44.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

25.68Industry Average 11.930.0Point

2.2x industry avg (risky)

PBR

3.40Industry Average 0.890.0Point

3.8x industry avg (risky)

ROE

14.05Industry Average 4.017.0Point

3.5x industry avg (excellent)

Debt Ratio

20.42Industry Average 12.430.5Point

1.6x industry avg (risky)

Trend 2024~20257.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.3% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲46.6% (1-year basis)

ROE Trend

2.5 / 4

Avg ROE 19.4% (declining, 2yr)

Detailed News Sentiment

11 totalPositive 10Neutral 0Negative 1Average Sentiment Score 82.3

Positive
김상우 듀켐바이오 대표 "진단사업 흑자 바탕으로 치료용 CDMO 본격 ...
듀켐바이오는 진단사업 흑자를 바탕으로 치료용 방사성의약품 CDMO 사업 확장을 추진하며 성장 기회를 모색하고 있다.
Positive
듀켐바이오, 알츠하이머병·전립선암 진단 수요 선제 대응위해 인재 ...
듀켐바이오가 알츠하이머병 및 전립선암 진단 분야의 성장에 맞춰 인재 확보에 집중함으로써 시장 수요에 적극 대응하고 있다.
Positive
듀켐바이오, 아시아 CDMO 기반 글로벌 방사성의약품 사업 확장 추진
듀켐바이오는 진단용 방사성의약품 생산 노하우를 활용해 아시아 지역 내 CDMO 사업을 확장하며 글로벌 시장 진출을 모색하고 있어 긍정적 전망을 제공합니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 5,880Won52-week high 11,68052-week low 5,880

1-month return0.0Point

1m -33.03% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral분기보고서 (2026.03)2026-05-14